The Effect of Kidney Transplantation and Immunosuppressive Therapy on Adipose Tissue Content and Adipocytokine Plasma Concentration-Preliminary Study
- PMID: 40699654
- PMCID: PMC12025913
- DOI: 10.3390/cimb47040255
The Effect of Kidney Transplantation and Immunosuppressive Therapy on Adipose Tissue Content and Adipocytokine Plasma Concentration-Preliminary Study
Abstract
Kidney transplantation is the preferred treatment for chronic kidney disease, significantly improving patient survival and quality of life. After the procedure, there is a gradual tendency to normalize most of the physiological and metabolic processes, but the need for immunosuppression may lead to new disorders related to the drugs' side effects and changes in proportions of body composition. The aim of the study was to analyze the concentrations of adipocytokines such as leptin, adiponectin, visfatin, and resistin, and to assess the body composition in patients with stabilized kidney graft function treated with tacrolimus, mycophenolate mofetil, and glucocorticosteroids. A total of 47 participants were enrolled, including 25 kidney transplant recipients on uniform immunosuppressive therapy and 22 healthy controls. The concentrations of leptin, adiponectin, and IL-6 in kidney transplant recipients was significantly higher than in the control group (p = 0.014, p = 0.031, p = 0.000, respectively), while the other adipocytokines, such as visfatin and resistin, do not obtain statistically significant differences. The bioelectrical impedance analysis showed statistically significant differences for fat-free mass index (p = 0.027), visceral fat area (p = 0.023), waist circumference (p = 0.006), fat mass (p = 0.028), and fat mass index (p = 0.034), all of which had higher mean values in the study group. Preliminary findings suggest that kidney transplantation leads to significant alterations in adipocytokines levels, with potential implications for metabolic health.
Keywords: adipocytokines; adipose tissue; chronic kidney disease; immunosuppressive therapy; kidney transplantation.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures

Similar articles
-
A systematic review and economic model of the clinical and cost-effectiveness of immunosuppressive therapy for renal transplantation in children.Health Technol Assess. 2006 Dec;10(49):iii-iv, ix-xi, 1-157. doi: 10.3310/hta10490. Health Technol Assess. 2006. PMID: 17134597
-
Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.Health Technol Assess. 2005 May;9(21):1-179, iii-iv. doi: 10.3310/hta9210. Health Technol Assess. 2005. PMID: 15899149
-
Cordyceps sinensis (a traditional Chinese medicine) for kidney transplant recipients.Cochrane Database Syst Rev. 2015 Oct 12;2015(10):CD009698. doi: 10.1002/14651858.CD009698.pub2. Cochrane Database Syst Rev. 2015. PMID: 26457607 Free PMC article.
-
Mycophenolic acid versus azathioprine as primary immunosuppression for kidney transplant recipients.Cochrane Database Syst Rev. 2015 Dec 3;2015(12):CD007746. doi: 10.1002/14651858.CD007746.pub2. Cochrane Database Syst Rev. 2015. PMID: 26633102 Free PMC article.
-
Belatacept for kidney transplant recipients.Cochrane Database Syst Rev. 2014 Nov 24;2014(11):CD010699. doi: 10.1002/14651858.CD010699.pub2. Cochrane Database Syst Rev. 2014. PMID: 25416857 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources